CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Qualigen Therapeutics, Inc. - QLGN CFD

    0.69
    0%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.07
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026207 %
    Charges from full value of position ($-4.98)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026207%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003985 %
    Charges from full value of position ($0.76)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.003985%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Key Stats
    Prev. Close* 0.69
    Open* 0.68
    1-Year Change* -62.43%
    Day's Range* 0.68 - 0.69
    52 wk Range 0.18-3.12
    Average Volume (10 days) 183.42K
    Average Volume (3 months) 4.46M
    Market Cap 8.42M
    P/E Ratio -100.00K
    Shares Outstanding 42.11M
    Revenue 4.79M
    EPS -0.47
    Dividend (Yield %) N/A
    Beta -0.38
    Next Earnings Date Mar 30, 2023

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Nov 29, 2023 0.69 0.01 1.47% 0.68 0.69 0.68
    Nov 28, 2023 0.69 -0.01 -1.43% 0.70 0.70 0.69
    Nov 27, 2023 0.66 0.01 1.54% 0.65 0.66 0.64
    Nov 24, 2023 0.65 -0.01 -1.52% 0.66 0.66 0.65
    Nov 22, 2023 0.66 -0.01 -1.49% 0.67 0.67 0.66
    Nov 21, 2023 0.69 0.02 2.99% 0.67 0.69 0.67
    Nov 20, 2023 0.69 0.03 4.55% 0.66 0.69 0.66
    Nov 17, 2023 0.69 0.02 2.99% 0.67 0.69 0.67
    Nov 16, 2023 0.70 0.00 0.00% 0.70 0.70 0.70
    Nov 15, 2023 0.68 0.00 0.00% 0.68 0.71 0.68
    Nov 14, 2023 0.69 0.00 0.00% 0.69 0.69 0.69
    Nov 10, 2023 0.66 -0.01 -1.49% 0.67 0.67 0.66
    Nov 9, 2023 0.65 -0.03 -4.41% 0.68 0.68 0.65
    Nov 8, 2023 0.69 -0.01 -1.43% 0.70 0.70 0.68
    Nov 7, 2023 0.71 0.03 4.41% 0.68 0.72 0.68
    Nov 6, 2023 0.67 -0.05 -6.94% 0.72 0.74 0.67
    Nov 3, 2023 0.70 0.00 0.00% 0.70 0.72 0.69
    Nov 2, 2023 0.71 0.01 1.43% 0.70 0.71 0.70
    Nov 1, 2023 0.72 0.00 0.00% 0.72 0.72 0.72
    Oct 31, 2023 0.74 -0.03 -3.90% 0.77 0.77 0.74

    Qualigen Therapeutics, Inc. Events

    Time (UTC) Country Event
    No events scheduled
    View all events
    • Annual
    • Quarterly
    2021 2020 2020 2019 2018
    Total revenue 5.65373 0 2.84956 0 0
    Total Operating Expense 28.3168 2.21508 14.2941 10.8442 16.9956
    Selling/General/Admin. Expenses, Total 12.2676 2.20947 7.41324 4.57093 5.42503
    Research & Development 11.7167 0.00182 3.3161 6.12697 11.3661
    Other Operating Expenses, Total 0.00379 0.14628 0.2044
    Operating Income -22.663 -2.21508 -11.4446 -10.8442 -16.9956
    Interest Income (Expense), Net Non-Operating 0.04269 0.01262 -0.04804 0.12305 0.12684
    Other, Net 4.72863 0.53509 -8.05375 0.58811 0
    Net Income Before Taxes -17.8917 -1.66737 -19.5464 -10.133 -16.8687
    Net Income After Taxes -17.8971 -1.66737 -19.5464 -10.133 -16.8687
    Net Income Before Extra. Items -17.8971 -1.66737 -19.5464 -10.133 -16.8687
    Total Extraordinary Items 0
    Net Income -17.8971 -1.66737 -19.5464 -10.133 -16.8687
    Total Adjustments to Net Income 0 -2.53784
    Income Available to Common Excl. Extra. Items -17.8971 -1.66737 -19.5464 -10.133 -19.4066
    Income Available to Common Incl. Extra. Items -17.8971 -1.66737 -19.5464 -10.133 -19.4066
    Diluted Net Income -17.8971 -1.66737 -19.5464 -10.133 -19.4066
    Diluted Weighted Average Shares 29.3349 1.39644 17.4317 0.3828 0.21219
    Diluted EPS Excluding Extraordinary Items -0.6101 -1.19402 -1.12131 -26.4706 -91.4598
    Diluted Normalized EPS -0.6101 -1.19402 -1.06827 -26.4706 -91.4598
    Dividends per Share - Common Stock Primary Issue 0 0
    Revenue 5.65373 2.84956
    Cost of Revenue, Total 4.33249 2.64015
    Gross Profit 1.32124 0.20941
    Unusual Expense (Income) 0.92466
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Total revenue 0.72203 1.48123 1.15507 1.11794 1.8995
    Revenue 0.72203 1.48123 1.15507 1.11794 1.8995
    Cost of Revenue, Total 0.82885 1.22026 0.99312 0.91662 1.20248
    Gross Profit -0.10682 0.26097 0.16195 0.20132 0.69702
    Total Operating Expense 5.73067 6.12867 5.96298 8.51273 7.71238
    Selling/General/Admin. Expenses, Total 3.03707 3.28285 2.88654 3.08764 3.01053
    Research & Development 1.86475 1.62556 2.08332 4.50847 3.49937
    Operating Income -5.00864 -4.64744 -4.80791 -7.39479 -5.81288
    Interest Income (Expense), Net Non-Operating 0.00631 0.00583 0.0068 0.01272 0.01734
    Other, Net 0.68328 0.42604 1.76464 1.98461 0.55335
    Net Income Before Taxes -4.31905 -4.21558 -3.03647 -5.39747 -5.24219
    Net Income After Taxes -4.31979 -4.21886 -3.03748 -5.39808 -5.24272
    Net Income Before Extra. Items -4.31979 -4.21886 -3.03748 -5.39808 -5.24272
    Net Income -4.31979 -4.21886 -3.03748 -5.39808 -5.24272
    Income Available to Common Excl. Extra. Items -4.31979 -4.21886 -3.03748 -5.39808 -5.24272
    Income Available to Common Incl. Extra. Items -4.31979 -4.21886 -3.03748 -5.39808 -5.24272
    Diluted Net Income -4.31979 -4.21886 -3.03748 -5.39808 -5.24272
    Diluted Weighted Average Shares 35.294 31.2875 29.0262 28.8505 28.1658
    Diluted EPS Excluding Extraordinary Items -0.12239 -0.13484 -0.10465 -0.18711 -0.18614
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.12239 -0.13484 -0.10465 -0.18711 -0.18614
    Other Operating Expenses, Total 0 0
    Total Adjustments to Net Income 0
    • Annual
    • Quarterly
    2021 2020 2020 2019 2018
    Total Current Assets 20.7964 6.12963 28.2247 2.21026 15.277
    Cash and Short Term Investments 17.5383 5.95289 23.9766 1.69997 14.801
    Cash & Equivalents 17.5383 5.95289 23.9766 1.69997 7.81226
    Prepaid Expenses 1.3799 0.17674 2.67889 0.50952 0.42152
    Total Assets 22.8357 6.68754 29.1268 2.79702 15.3199
    Property/Plant/Equipment, Total - Net 1.84978 0.07984 0.69607 0.10869 0.02016
    Other Long Term Assets, Total 0.01833 0.47808 0.01833 0.47808 0.02273
    Total Current Liabilities 4.63548 1.6724 10.4301 1.69705 5.93352
    Accounts Payable 0.88622 1.29011 0.50077 1.41732 4.51232
    Accrued Expenses 1.86409 0.3823 0.96608 0.27973 1.40784
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 1.88516 8.83153 0.01336
    Total Liabilities 6.27097 1.6724 10.8322 1.69705 5.93352
    Total Long Term Debt 0 0 0.00697 0 0
    Total Equity 16.5647 5.01514 18.2946 1.09998 9.38638
    Preferred Stock - Non Redeemable, Net 0.24 0 1.52896 8.07626
    Common Stock 0.03529 0.04571 0.0273 0.01911 0.00604
    Additional Paid-In Capital 101.274 86.73 85.1148 79.8851 71.5052
    Retained Earnings (Accumulated Deficit) -84.7446 -82.0005 -66.8475 -80.3332 -70.2001
    Total Liabilities & Shareholders’ Equity 22.8357 6.68754 29.1268 2.79702 15.3199
    Total Common Shares Outstanding 35.2902 1.82856 27.2961 0.76433 0.24146
    Short Term Investments 0 6.98878
    Total Receivables, Net 0.82235 0 0.61576 0.00077 0.05446
    Property/Plant/Equipment, Total - Gross 5.43517 0.10198 4.11821 0.12937 0.03475
    Accumulated Depreciation, Total -3.58538 -0.02214 -3.42215 -0.02068 -0.01459
    Other Equity, Total 0 -0.00092
    Total Preferred Shares Outstanding 0.00209
    Accounts Receivable - Trade, Net 0.82235 0.61576
    Total Inventory 1.05588 0.95346
    Intangibles, Net 0.17119 0.18769
    Current Port. of LT Debt/Capital Leases 0 0.13177
    Long Term Debt 0 0.00697
    Other Liabilities, Total 1.63549 0.3951
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Total Current Assets 16.7038 20.7964 15.7329 19.1065 24.9158
    Cash and Short Term Investments 13.6109 17.5383 12.3198 15.2324 21.9479
    Cash & Equivalents 13.6109 17.5383 12.3198 15.2324 21.9479
    Total Receivables, Net 0.59434 0.82235 0.63355 0.76691 0.86224
    Accounts Receivable - Trade, Net 0.59434 0.82235 0.63355 0.76691 0.86224
    Total Inventory 1.40071 1.05588 1.17801 1.07334 0.88586
    Prepaid Expenses 1.09782 1.3799 1.60151 2.03386 1.21976
    Total Assets 18.7085 22.8357 16.4046 19.8889 25.7356
    Property/Plant/Equipment, Total - Net 1.82154 1.84978 0.47579 0.58016 0.61224
    Property/Plant/Equipment, Total - Gross 5.20516 5.21011 3.81407 4.03456 4.04944
    Accumulated Depreciation, Total -3.38363 -3.36032 -3.33828 -3.45441 -3.4372
    Intangibles, Net 0.16482 0.17119 0.17756 0.18393 0.18929
    Other Long Term Assets, Total 0.01833 0.01833 0.01833 0.01833 0.01833
    Total Current Liabilities 3.62571 4.63548 5.427 7.41691 9.19683
    Accounts Payable 0.99741 0.88622 0.9087 0.78447 0.48555
    Accrued Expenses 1.42257 1.86409 2.02428 2.14423 2.07428
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 0 0 0 0.01068
    Other Current Liabilities, Total 1.20573 1.88516 2.49402 4.4882 6.62631
    Total Liabilities 5.19162 6.27097 5.55848 7.62711 9.50524
    Total Long Term Debt 0 0 0 0 0.00492
    Long Term Debt 0 0 0 0.00492
    Other Liabilities, Total 1.56591 1.63549 0.13149 0.2102 0.30349
    Total Equity 13.5168 16.5647 10.8461 12.2618 16.2304
    Preferred Stock - Non Redeemable, Net 0 0 0
    Common Stock 0.0353 0.03529 0.02908 0.0289 0.02883
    Additional Paid-In Capital 102.546 101.274 89.5009 88.0583 86.7217
    Retained Earnings (Accumulated Deficit) -89.0644 -84.7446 -78.6839 -75.8253 -70.5201
    Total Liabilities & Shareholders’ Equity 18.7085 22.8357 16.4046 19.8889 25.7356
    Total Common Shares Outstanding 35.2955 35.2902 29.0821 28.9022 28.8331
    Total Preferred Shares Outstanding 0.00018 0.00018
    • Annual
    • Quarterly
    2021 2020 2020 2019 2018
    Net income/Starting Line -17.8971 -1.66737 -19.5464 -10.133 -16.8687
    Cash From Operating Activities -14.7307 -1.16384 -10.1629 -14.5167 -13.3329
    Cash From Operating Activities 0.11322 0.00146 0.08838 0.00609 0.00572
    Non-Cash Items 1.19921 -0.45162 12.2797 -0.05343 -0.26871
    Changes in Working Capital 1.85397 0.95369 -2.98461 -4.33634 3.79878
    Cash From Investing Activities -0.14136 0 -0.06509 6.99696 -6.971
    Capital Expenditures -0.14136 -0.21492 -0.00159 -0.00201
    Cash From Financing Activities 8.43381 5.41676 34.0515 1.40744 5.48421
    Financing Cash Flow Items -0.70693 -0.15688 -1.3608 -0.04963 -0.51579
    Issuance (Retirement) of Stock, Net 9.27948 5.57364 35.3433 1.45707 6
    Net Change in Cash -6.4383 4.25292 23.8235 -6.11229 -14.8197
    Cash Taxes Paid 0.00513 -0.01452 0.00477 0.1871 -0.00223
    Other Investing Cash Flow Items, Total 0 0.14983 6.99855 -6.96899
    Cash Interest Paid 0.00123 0.03269
    Issuance (Retirement) of Debt, Net -0.13874 0.06893
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Net income/Starting Line -4.31979 -17.8971 -13.6783 -10.6408 -5.24272
    Cash From Operating Activities -3.88161 -14.7307 -11.8174 -8.78506 -2.0811
    Cash From Operating Activities 0.02975 0.11322 0.0824 0.05374 0.02745
    Non-Cash Items 0.29359 1.19921 -0.28703 0.07473 1.00245
    Cash Taxes Paid 0 0.00513 0.0022 0.0022 0.0001
    Cash Interest Paid 0 0.00123 0.00123 0.00168 0.00083
    Changes in Working Capital 0.11484 1.85397 2.0655 1.72727 2.13172
    Cash From Investing Activities -0.04963 -0.14136 -0.12436 -0.11469 -0.069
    Capital Expenditures -0.04963 -0.14136 -0.12436 -0.11469 -0.069
    Cash From Financing Activities 0.00386 8.43381 0.28501 0.15558 0.12145
    Issuance (Retirement) of Stock, Net 0.00386 9.27948 0.42374 0.29432 0.24458
    Issuance (Retirement) of Debt, Net 0 -0.13874 -0.13874 -0.13874 -0.12313
    Net Change in Cash -3.92738 -6.4383 -11.6568 -8.74417 -2.02866
    Financing Cash Flow Items -0.70693

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Qualigen Therapeutics, Inc. Company profile

    Qualigen, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system; ALAN, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; AS1411 for treating viral-based infectious diseases; RAS-F3, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient''s blood. Qualigen, Inc. was founded in 1996 and is based in Carlsbad, California.
    Industry: Biotechnology & Medical Research (NEC)

    1880 Century Park E Ste 1000
    90067

    Income Statement

    • Annual
    • Quarterly

    News

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023
    GBP

    UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?

    UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.

    10:48, 21 November 2023

    Gold Rises as Traders price-in Fed Rate Cuts

    Gold prices have declined despite a drop in Treasury yields and a weaker US Dollar. We look at the key drivers and technical levels for the gold price.

    13:17, 20 November 2023

    People also watch

    Gold

    2,041.54 Price
    -0.160% 1D Chg, %
    Long position overnight fee -0.0196%
    Short position overnight fee 0.0114%
    Overnight fee time 22:00 (UTC)
    Spread 0.50

    Oil - Crude

    78.92 Price
    +1.370% 1D Chg, %
    Long position overnight fee -0.0163%
    Short position overnight fee -0.0056%
    Overnight fee time 22:00 (UTC)
    Spread 0.040

    US100

    16,044.50 Price
    +0.300% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 1.8

    BTC/USD

    37,913.10 Price
    +0.180% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading